Related Experiment Video
Updated: May 26, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Phosphoproteomic analysis of mouse thymoma cells treated with tributyltin oxide: TBTO affects proliferation and
Ahmed M Osman1, Henk van Loveren
1National Institute for Public Health and the Environment (RIVM), NL-3720 BA Bilthoven, The Netherlands. ahmed.osman@rivm.nl
Abstract:
We report the results of phosphoproteomic analysis of mouse thymoma cells treated with tributyltin oxide (TBTO), an immunotoxic compound. After cell lysis, phosphoproteins were isolated using Phosphoprotein Purification Kit, separated by SDS-PAGE and subsequently digested with trypsin. Phosphopeptides were enriched employing titanium dioxide, and the obtained fractions were analyzed by nano-LC-MS/MS. A total of 160 phosphoproteins and 328 phosphorylation sites were identified in thymoma cells. Among the differentially phosphorylated proteins identified in TBTO-treated cells were key enzymes, which catalyze rate-limiting steps in pathways that are sensitive to cellular energy status. These proteins included acetyl-CoA carboxylase isoform 1, which catalyzes the rate-limiting step of fatty acid synthesis. Another enzyme was glutamine: fructose-6-phosphate amidotransferase, GFAT1, the first and rate-limiting enzyme for the hexoamine synthesis pathway. Pyruvate dehydrogenase (PDH), a multicomplex enzyme that catalyzes the rate-limiting step of aerobic oxidation of fuel carbohydrates, was identified in both TBTO-treated and control cells; however, phosphorylation at residue S293, known to inhibit PDH activity, was identified only in control cells. A lower expression level of ribosomal protein S6 kinase 1, a downstream kinase of the mammalian target of rapamycin signaling pathway implicated in protein synthesis through phosphorylation of 40 ribosomal S6, was observed in the treated cells. Giant kinases like AMP-activated protein kinase (AMPK) and cAMP-dependent protein kinase (PKAR1A), which are known to mediate the phosphorylation of these enzymes, were identified in TBTO-treated cells. Downregulation of proteins, such as MAPK, matrin-3 and ribonucleotide reductase, subunit RRM2, which are implicated in cell proliferation, was also observed in TBTO-treated cells. Together, the results show that TBTO affects proliferation and energy sensor pathways.
Insights
Tributyltin oxide (TBTO) exposure alters key enzymes in cellular energy pathways and impacts cell proliferation in mouse thymoma cells. This phosphoproteomic study reveals TBTO
Area of Science:
- Proteomics
- Cellular Biology
- Toxicology
Background:
- Tributyltin oxide (TBTO) is an immunotoxic compound.
- Understanding TBTO's molecular effects is crucial for assessing its toxicological impact.
Purpose of the Study:
- To investigate the phosphoproteomic changes in mouse thymoma cells induced by TBTO exposure.
- To identify key signaling pathways and proteins affected by TBTO.
Main Methods:
- Phosphoproteomic analysis using nano-LC-MS/MS.
- Isolation and enrichment of phosphoproteins and phosphopeptides.
- SDS-PAGE and trypsin digestion of proteins.
Main Results:
- Identified 160 phosphoproteins and 328 phosphorylation sites.
- TBTO treatment altered phosphorylation of enzymes in fatty acid and hexosamine synthesis pathways.
- Downregulation of proteins involved in cell proliferation (MAPK, RRM2) observed.
Conclusions:
- TBTO significantly affects cellular energy metabolism and proliferation pathways.
- Phosphoproteomic analysis provides insights into the molecular mechanisms of TBTO toxicity.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
